These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4746586)

  • 21. [Significance of the isoniazid inactivation in the therapy of pulmonary tuberculosis].
    Gol'dshteĭn VD; Ioffe RA; Ponomareva ES
    Probl Tuberk; 1970; 48(1):34-9. PubMed ID: 5425443
    [No Abstract]   [Full Text] [Related]  

  • 22. [The different inactivation of isoniazid in intermittent chemotherapy (author's transl)].
    Iwainsky H; Eule H; Fischer P; Werner E; Winsel K; Franke H
    Z Erkr Atmungsorgane; 1977; 147(1):41-50. PubMed ID: 405809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
    Kanevskaia SS; Rzhavskov IuV
    Probl Tuberk; 1967; 45(10):44-8. PubMed ID: 5617546
    [No Abstract]   [Full Text] [Related]  

  • 24. [Indicators of INH inactivation determined using a biological method and its use in monitoring antitubercular treatment].
    Czaplińska-Jóźwiak E; Szymański A; Dutkiewicz J
    Pneumonol Pol; 1986 Dec; 54(12):535-40. PubMed ID: 3588330
    [No Abstract]   [Full Text] [Related]  

  • 25. Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis.
    GANGADHARAM PR; BHATIA AL; RADHAKRISHNA S; SELKON JB
    Bull World Health Organ; 1961; 25(6):765-77. PubMed ID: 13896634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Decomposition of INH and cycloserin preparations in the body of patients with tuberculosis of the lungs].
    Smirnov GA
    Probl Tuberk; 1977 Aug; (8):63-6. PubMed ID: 905277
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical pharmacology of isoniazid].
    Sokolova GV; Ivleva AIa; Ziia AV; Zeliger LR; Suvorova VI
    Probl Tuberk; 1984 Sep; (9):55-60. PubMed ID: 6504886
    [No Abstract]   [Full Text] [Related]  

  • 28. Intermittent chemotherapy of pulmonary tuberculosis using rifampicin and isoniazid for primary treatment: the influence of various factors on the frequency of side-effects.
    Eule H; Werner E; Winsel K; Iwainsky H
    Tubercle; 1974 Mar; 55(1):81-9. PubMed ID: 4620295
    [No Abstract]   [Full Text] [Related]  

  • 29. [Type of isoniazid (INH) acetylation determined in tuberculosis patients treated at the Institute of Tuberculosis and Lung Diseases in Warsaw during the years 1990-1997].
    Augustynowicz-Kopeć E; Zwolska Z
    Pneumonol Alergol Pol; 2002; 70(3-4):180-92. PubMed ID: 12271965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diphenylhydantoin intoxication attendant to slow inactivation of isoniazid.
    Brennan RW; Dehejia H; Kutt H; McDowell F
    Neurology; 1968 Mar; 18(3):283. PubMed ID: 5690351
    [No Abstract]   [Full Text] [Related]  

  • 31. [Isoniazid metabolism and the indicators of bioelectric activity of the brain in patients with tuberculosis during treatment with increased doses of isoniazid].
    Vilenskaia RN; Chelnokova NV
    Probl Tuberk; 1976; 3():46-9. PubMed ID: 967856
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetic studies with an isoniazid slow-releasing matrix preparation.
    Eidus L; Hodgkin MM; Hsu AH; Schaefer O
    Am Rev Respir Dis; 1974 Jul; 110(1):34-42. PubMed ID: 4834616
    [No Abstract]   [Full Text] [Related]  

  • 33. [Percentage ratio of free- and acetyl-INH in the urine as a method of determination of the INH inactivation pattern].
    Rózniecki J
    Gruzlica; 1968 Oct; 36(10):971-3. PubMed ID: 5715459
    [No Abstract]   [Full Text] [Related]  

  • 34. [Rate of acetylation of isoniazid in pulmonary tuberculosis and its relationship with effect and side-effects of treatment (author's transl)].
    Zhang LX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1981 Dec; 4(6):349-51. PubMed ID: 7344873
    [No Abstract]   [Full Text] [Related]  

  • 35. Importance of acetylation and oxidation in inactivation of isonicotinic acid hydrazide preparations.
    Smirnov GA
    Fed Proc Transl Suppl; 1966; 25(1):72-6. PubMed ID: 5322111
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inactivation of PAS and isoniazid in children with tuberculosis].
    Shenderova RI; Terterian EA
    Probl Tuberk; 1973; 51(5):67-71. PubMed ID: 4757049
    [No Abstract]   [Full Text] [Related]  

  • 37. Classification of subjects as slow or rapid inactivators of isoniazid based on the ratio of acetylisoniazid to isoniazid in urine determined by a simple colorimetric method.
    Raghupati Sarma G; Kailasam S; Kannapiran M; Krishnaswami KV; Thomas L; Nair NG; Narayana AS
    Indian J Med Res; 1976 Oct; 64(10):1456-61. PubMed ID: 1017858
    [No Abstract]   [Full Text] [Related]  

  • 38. Isoniazid and ethionamide serum levels and inactivation in Finnish subjects.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(2):110-24. PubMed ID: 5195839
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of patients with pulmonary tuberculosis--strong and weak GINK inactivators].
    Katslan IaD
    Probl Tuberk; 1972; 50(3):36-8. PubMed ID: 5037240
    [No Abstract]   [Full Text] [Related]  

  • 40. [A comparative study of tubazid inactivation in patients with pulmonary tuberculosis with fractional and single daily doses].
    Vilenskaia RN; Grebennik LI; Adamovich VN
    Probl Tuberk; 1969; 47(3):43-9. PubMed ID: 5354635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.